2019.10.31

MamStartup: Innovative veterinary therapies

Mamstartup: Gallant has developed a non invasive method for retrieving stem cells which can be used to treat various ailments – from torn ... More
2019.10.08

A Polish startup wants to improve the way we fight diseases in dogs and cats

Business Insider caught up with Łukasz Bzdzion, founder of the startup Bioceltix, who – together with his team – is developing ... More
2019.10.03

Business Insider Trends Festival 2019 and Bioceltix

Trends Festival? We had to be there! It’s the most important event for the business community organized by Business Insider Polska. An ... More
2019.09.06

My Company Polska: Bioceltix among the 25 best Polish startups

My Company Polska has selected the 25 hottest and best startups – and we’re among them! The stem-cell-based pharmaceuticals, which ... More
2019.09.06

Rzeczpospolita: Millions for Polish medicine for horses

Rzczpospolita: The Wroclaw-based biotech, which is working on breakthrough biopharmaceuticals intended for animals, has received additional ... More
2019.08.09

We’re looking an R&D Specialist

We’re looking to expand and are in search of a new team member. Who is it that we’re looking for? An R&D Specialist. This person should have ... More
2019.07.15

NCBR focuses on modern medicine

In the years to come, we are going to see a crop of biotechnology and other projects with global potential. Breakthrough innovations will not ... More
2019.07.01

Parkiet: Bioceltix. A Wrocław startup thinks about the stock market

Parkiet: Bioceltix has been developing its own pharmaceuticals since 2016. It is also one of the first companies in Europe to complete a full EMA ... More
2019.06.26

VetHealth Global 2019

We are in Canada at the VetHealth Global 2019! Every two years, senior executives, emerging companies, investors, regulators, and researchers ... More
2019.06.25

PFR BioMed Academy: Bioceltix

We’re excited to announced that we are officially „enrolled” in the PFR BioMed Academy – an educational program designed specifically for ... More